Author

Kayla Molison

University of Colorado BoulderPrimary ORCID profile (0009-0001-6220-7619 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Kayla MolisoniD1 paper · Children's Hospital Colorado

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin EricksoniD· 1 shared David L. BentleyiD· 1 shared Deepa AjitiD· 1 shared Dylan J. TaatjesiD· 1 shared Joaquin Maximiliano EspinosaiD· 1 shared Kira Cozzolino· 1 shared Lynn SanfordiD· 1 shared Mary Ann AlleniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Benjamin EricksonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome

Kira Cozzolino, Lynn Sanford, Samuel Hunter, Kayla Molison, Benjamin Erickson, Meaghan CS Courvan, Taylor Jones, Deepa Ajit, Matthew D. Galbraith, Joaquin Maximiliano Espinosa, David L. Bentley, Mary Ann Allen, Robin D. Dowell, Dylan J. Taatjes

This study shows that inhibiting Mediator kinases CDK8/CDK19 suppresses hyperactive IFN signaling in Down syndrome by affecting transcription, splicing, and lipid metabolism.

eLife · Feb 10, 2025Peer-reviewedMolecular Biology